Kashmolah Ghazi 4/A
4/A · Lucira Health, Inc. · Filed Aug 24, 2022
Insider Transaction Report
Form 4/AAmended
Kashmolah Ghazi
Ex. VP &Chief Quality Officer
Transactions
- Sale
Common Stock
2022-08-17$2.52/sh−19,074$48,066→ 180,757 total
Footnotes (3)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares.
- [F2]This amendment corrects the price of the shares sold, which was inadvertently incorrectly reported on the original Form 4.
- [F3]Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.